Skip to main content
Fig. 2 | Trials

Fig. 2

From: Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial

Fig. 2

Schedule of enrolment, interventions, and assessments. Superscript number 1 indicates treatment failure can occur at any time. Superscript number 2 indicates rectal swab samples are not collected at month 6. Superscript number 3 indicates collected every 3 months

Back to article page

Trials

ISSN: 1745-6215